Argus Investors Counsel’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Argus Investors Counsel's BMY Position: Q4 2018 in Review
Argus Investors Counsel sold out of Bristol-Myers Squibb (BMY) in Q4 2018, closing a stake of 5,854 shares — an estimated $363K sold.
Argus Investors Counsel first reported a position in BMY in Q2 2018 and held it in 2 quarters. The position peaked at $363K in Q3 2018. 1,766 funds tracked by Wall St. Rank hold BMY as of Q4 2018.
- Argus Investors Counsel reported no remaining Bristol-Myers Squibb position as of Q4 2018 after selling out during the quarter.
- Argus Investors Counsel sold 5,854 Bristol-Myers Squibb shares in Q4 2018, an estimated $363K.
- Argus Investors Counsel first reported a position in Bristol-Myers Squibb in Q2 2018 and held it in 2 quarters.
- Argus Investors Counsel's Bristol-Myers Squibb position peaked at $363K in Q3 2018.
- 1,766 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2018.
Based on Argus Investors Counsel's 13F filing for Q4 2018, filed 6 Feb 2019.